Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

High androgen levels in young women with PCOS are linked to higher blood pressure.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

New treatments for PCOS show promise, including both medication and non-medication options.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Overexpressing a specific enzyme in mice causes hair loss and female infertility.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Most patients' skin darkening after sclerotherapy fades on its own within 6-24 months.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Postinflammatory hyperpigmentation causes dark skin patches and needs personalized treatment.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.